Cenova Capital
Cenova Capital is a venture capital firm based in Shanghai, China, founded in 2010 by Dr. Jun Wu. The firm specializes in late venture and growth stage investments in the life sciences and healthcare sectors. Cenova focuses on various sub-sectors, including pharmaceuticals, medical technology, specialized healthcare services, precision medicine, e-health, and innovative medical devices and diagnostics. As one of the earliest dedicated healthcare investment firms in China, Cenova has played a significant role in transitioning the country's healthcare system from a state-owned model to a more market-oriented approach. The firm manages five funds and has invested in over 50 companies, with its investors primarily comprising large domestic and international institutional entities, such as sovereign wealth funds, government institutions, and multinational companies.
Luqa Pharmaceuticals Co., Ltd. is a specialty pharmaceutical company focused on the Chinese market, primarily engaged in the acquisition, development, and commercialization of healthcare products. The company offers a diverse portfolio that includes dermatological and oral care products. Its dermatological offerings feature Ebernet, an eberconazole cream for fungal skin infections, and Strataderm, a silicone gel for scar treatment and prevention. In the oral care segment, Luqa provides Lacteol, a probiotic for infants and immunocompromised patients, and GelX, a medical device for managing oral cavity pain from conditions like mucositis and stomatitis. Other products include GelX Xero for dry mouth relief, Aftacure for oral mucosal lesions, Ialuxid Gel for post-surgical wounds, and Podofilm for benign epithelial formations. Established in 2010 and based in Central, Hong Kong, Luqa Pharmaceuticals is dedicated to enhancing patient quality of life through innovative healthcare solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.